Tarsier : Bloomsmore Financials Nov 30 2021

/////

Bloomsmore Group Ltd

FORMERLY Tarsier Ltd

CONSOLIDATED FINANCIAL STATEMENTS

For the Six Months Ended

November 30, 2021

(UNAUDITED)

BLOOMSMORE GROUP LTD (FORMERLY TARSIER LTD)

FOR THE SIX MONTHS ENDED NOVEMBER 30, 2021
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Financial Statements
Consolidated Balance Sheets (Unaudited) at November 30, 2021 and May 31, 2021	F-1
Consolidated Statements of Operations (Unaudited) for the three and six months ended November 30, 2021 and 2020	F-2
Consolidated Statements of Stockholders' Deficit (Unaudited) for the three months ended November 30, 2021	F-3
Consolidated Statements of Stockholders' Deficit (Unaudited) for the six months ended November 30, 2021	F-4
Consolidated Statements of Stockholders' Deficit (Unaudited) for the three months ended November 30, 2020	F-5
Consolidated Statements of Stockholders' Deficit (Unaudited) for the six months ended November 30, 2020	F-6
Consolidated Statements of Cash Flows (Unaudited) for the six months ended November 30, 2021 and 2020	F-7
Notes to Unaudited Consolidated Financial Statements	F-8

-1-

BLOOMSMORE GROUP LTD (FORMERLY TARSIER LTD)

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

		November 30,			May 31,
		2021			2021
ASSETS
Cash	$	81	$	0
Total assets	$	81		$	0
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accrued interest	$	814,921		$	738,596
Convertible notes payable		465,388			438,890
Notes payable		259,500			259,500
Related party advances		114,665			109,545
Derivative liability		1,214,633			6,038,786
Total liabilities		2,869,107			7,585,317
Commitments and contingencies (Note 5)
Stockholder's equity (deficit)
Preferred stock, $0.001 par value, 10,000,000 shares authorized;
Series C: 100,000 and 50,000 issued and outstanding as of November 30,
2021 and May 31, 2021, respectively		50			100
Common stock, $0.001 par value; 150,000,000 shares authorized; 110,719,237
and 63,219,000 issued and outstanding as of November 30, 2021 and May 31,
2021, respectively		110,719			63,219
Common stock to be issued		5,300			5,300
Additional paid in capital		8,939,336			8,986,786
Accumulated deficit		(11,924,431)			(16,640,722)
Total stockholders' equity (deficit)		(2,869,026)			(7,585,317)
Total liabilities and stockholders' equity (deficit)	$	81		$	0

The accompanying notes are an integral part of these unaudited financial statements

F-1

BLOOMSMORE GROUP LTD (FORMERLY TARSIER LTD)

STATEMENTS OF OPERATIONS

(UNAUDITED)

		For the three months ended			For the six months ended
		November 30,					November 30,
		2021			2020			2021				2020
Revenues	$	-		$	-		$	-			$	-
Operating expenses:
Personnel expenses		15,000			-			30,000				-
General & administrative expenses		5,909			-			23,039				-
Professional fees		-			-			2,000				-
Total operating expenses		20,909			-			55,039				-
Net operating loss		(20,909)			-			(55,039)				-
Other income (expense):
Interest expense		(38,372)			(37,954)			(76,325)				(61,679)
Amortization of debt discount		(14,197)			-			(15,669)				-
Change in fair value of derivative liabilities		1,045,238			(2,514,276)			4,863,324				(2,412,831)
Total other income (expense)		992,669			(2,552,230)			4,771,330				(2,474,510)
Net income (loss)	$	971,760		$	(2,552,230)		$	4,716,291			$	(2,474,510)
Basic and diluted loss per share	$	0.00		$	(0.00)		$	0.00			$	(0.00)
Weighted average number of shares outstanding, basic and diluted		110,719,237			63,219,237			89,318,138				63,219,237

The accompanying notes are an integral part of these unaudited financial statements

F-2

BLOOMSMORE GROUP LTD

(FORMERLY TARSIER LTD)

STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE SIX MONTHS ENDED NOVEMBER 30, 2021

(UNAUDITED)

	Series C
Preferred Stock			Common Stock	Common Stock		Additional Paid-In
Shares		Amount		Shares			Amount		To Be Issued		Capital

Accumulated
Deficit	Total

Balance, June 1, 2021

100,000

$

100

Conversion of Series C
Preferred stock to common
stock	(50,000)			(50)
Cancellation of Common Stock	-			-
Net income	-			-
Balance, November 30, 2021	50,000		$	50

63,219,237

$

63,219

$

5,300

$

8,986,786

	50,000,000			50,000			-			(49,950)
	(2,500,000)			(2,500)			-			2,500
	-			-			-			-
	110,719,237		$	110,719		$	5,300		$	8,939,336

$	(16,640,722)	$	(7,585,317)
	-		-
	-		-
	4,716,291		4,716,291
$	(11,924,431)	$	(2,869,026)

The accompanying notes are an integral part of these unaudited financial statements

F-3